middle.news
Technegas Clinched as Preferred Lung Imaging Agent in New US Guideline
9:08am on Tuesday 27th of January, 2026 AEDT
•
Healthcare
Read Story
Technegas Clinched as Preferred Lung Imaging Agent in New US Guideline
9:08am on Tuesday 27th of January, 2026 AEDT
Key Points
Technegas named preferred ventilation agent in US draft lung imaging guideline
Guideline developed by leading nuclear medicine societies across US, Europe, Australia, and Canada
Recognition expected to accelerate Technegas adoption and hospital integration in the US
Guideline expands Technegas use beyond pulmonary embolism to multiple lung conditions
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cyclopharm (ASX:CYC)
OPEN ARTICLE